Semsarian C, Ingles J, Maron MS, Maron BJ (2015) New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol 65(12):1249–1254. https://doi.org/10.1016/j.jacc.2015.01.019

Article  PubMed  Google Scholar 

Nishimura RA, Ommen SR, Tajik AJ (2003) Cardiology patient page. Hypertrophic cardiomyopathy: a patient perspective Circulation 108(19):e133–e135

PubMed  Google Scholar 

Maron BJ, Rowin EJ, Maron MS (2018) Global burden of hypertrophic cardiomyopathy. JACC Heart Fail 6(5):376–378. https://doi.org/10.1016/j.jchf.2018.03.004

Article  PubMed  Google Scholar 

Maron BJ, Rowin EJ, Casey SA, Maron MS (2016) How hypertrophic cardiomyopathy became a contemporary treatable genetic disease with low mortality: shaped by 50 years of clinical research and practice. JAMA Cardiol 1(1). https://doi.org/10.1001/jamacardio.2015.0354

Park YM (2023) Updated risk assessments for sudden cardiac death in hypertrophic cardiomyopathy patients with implantable cardioverter-defibrillator. Korean J Intern Med 38(1). https://doi.org/10.3904/kjim.2022.144

Maron BJ, Rowin EJ, Maron MS (2021) Evolution of risk stratification and sudden death prevention in hypertrophic cardiomyopathy: twenty years with the implantable cardioverter-defibrillator. Heart Rhythm 18(6):1012–1023. https://doi.org/10.1016/j.hrthm.2021.01.019

Article  PubMed  Google Scholar 

Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P et al (2020) 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 142(25):e558–e631. https://doi.org/10.1161/CIR.0000000000000937

Article  PubMed  Google Scholar 

Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P et al (2014) 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 35(39):2733–2779. https://doi.org/10.1093/eurheartj/ehu284

Article  PubMed  Google Scholar 

Maron BJ, Maron MS, Maron BA, Loscalzo J (2019) Moving beyond the sarcomere to explain heterogeneity in hypertrophic cardiomyopathy: JACC review topic of the week. J Am Coll Cardiol 73(15):1978–1986. https://doi.org/10.1016/j.jacc.2019.01.061

Article  PubMed  PubMed Central  Google Scholar 

Maron BJ, Maron MS (2013) Hypertrophic cardiomyopathy. Lancet (London, England) 381(9862):242–255. https://doi.org/10.1016/S0140-6736(12)60397-3

Article  PubMed  Google Scholar 

Seidman CE, Seidman JG (2011) Identifying sarcomere gene mutations in hypertrophic cardiomyopathy: a personal history. Circ Res 108(6):743–750. https://doi.org/10.1161/CIRCRESAHA.110.223834

Article  CAS  PubMed  Google Scholar 

Marian AJ, Braunwald E (2017) Hypertrophic cardiomyopathy genetics, Pathogenesis, clinical manifestations, diagnosis, and therapy. Circ Res 121(7):749–770. https://doi.org/10.1161/circresaha.117.311059

Article  CAS  PubMed  PubMed Central  Google Scholar 

Prondzynski M, Mearini G, Carrier L (2019) Gene therapy strategies in the treatment of hypertrophic cardiomyopathy. Pflugers Arch 471(5):807–815. https://doi.org/10.1007/s00424-018-2173-5

Article  CAS  PubMed  Google Scholar 

Khera AV, Mason-Suares H, Brockman D, Wang M, VanDenburgh MJ, Senol-Cosar O et al (2019) Rare genetic variants associated with sudden cardiac death in adults. J Am Coll Cardiol 74(21):2623–2634. https://doi.org/10.1016/j.jacc.2019.08.1060

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shen H, Dong S-Y, Ren M-S, Wang R (2022) Ventricular arrhythmia and sudden cardiac death in hypertrophic cardiomyopathy: from bench to bedside. Frontiers In Cardiovascular Medicine 9:949294. https://doi.org/10.3389/fcvm.2022.949294

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chida A, Inai K, Sato H, Shimada E, Nishizawa T, Shimada M et al (2017) Prognostic predictive value of gene mutations in Japanese patients with hypertrophic cardiomyopathy. Heart Vessels 32(6):700–707. https://doi.org/10.1007/s00380-016-0920-0

Article  PubMed  Google Scholar 

Fraysse B, Weinberger F, Bardswell SC, Cuello F, Vignier N, Geertz B et al (2012) Increased myofilament Ca2+ sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice. J Mol Cell Cardiol 52(6):1299–1307. https://doi.org/10.1016/j.yjmcc.2012.03.009

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jacoby D, McKenna WJ (2012) Genetics of inherited cardiomyopathy. Eur Heart J 33(3):296–304. https://doi.org/10.1093/eurheartj/ehr260

Article  CAS  PubMed  Google Scholar 

Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA et al (2022) 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 43(40):3997–4126. https://doi.org/10.1093/eurheartj/ehac262

Article  PubMed  Google Scholar 

Arbelo E, Protonotarios A, Gimeno JR, Arbustini E, Barriales-Villa R, Basso C et al (2023) 2023 ESC Guidelines for the management of cardiomyopathies. Eur Heart J. https://doi.org/10.1093/eurheartj/ehad194

Article  PubMed  Google Scholar 

Finocchiaro G, Sheikh N, Leone O, Westaby J, Mazzarotto F, Pantazis A et al (2021) Arrhythmogenic potential of myocardial disarray in hypertrophic cardiomyopathy: genetic basis, functional consequences and relation to sudden cardiac death. Europace 23(7):985–995. https://doi.org/10.1093/europace/euaa348

Article  PubMed  Google Scholar 

Pelliccia F, Cecchi F, Olivotto I, Camici PG (2022) Microvascular dysfunction in hypertrophic cardiomyopathy. J Clin Med 11(21). https://doi.org/10.3390/jcm11216560

Maron BJ (2010) Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy. Circulation 121(3):445–456. https://doi.org/10.1161/CIRCULATIONAHA.109.878579

Article  PubMed  Google Scholar 

Coppini R, Ferrantini C, Yao L, Fan P, Del Lungo M, Stillitano F et al (2013) Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy. Circulation 127(5):575–584. https://doi.org/10.1161/CIRCULATIONAHA.112.134932

Article  CAS  PubMed  Google Scholar 

Coppini R, Ferrantini C, Del Lungo M, Stillitano F, Sartiani L, Tosi B et al (2013) Response to letter regarding article, “Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy.” Circulation 128(10):e157. https://doi.org/10.1161/CIRCULATIONAHA.113.004016

Article  PubMed  Google Scholar 

Tashiro N, Muneuchi J, Ezaki H, Kobayashi M, Yamada H, Sugitani Y et al (2022) Ventricular repolarization dispersion is a potential risk for the development of life-threatening arrhythmia in children with hypertrophic cardiomyopathy. Pediatr Cardiol 43(7):1455–1461. https://doi.org/10.1007/s00246-022-02867-3

Article  PubMed  Google Scholar 

Cheng Z, Fang T, Huang J, Guo Y, Alam M, Qian H (2021) Hypertrophic cardiomyopathy: from phenotype and pathogenesis to treatment. Frontiers In Cardiovascular Medicine 8:722340. https://doi.org/10.3389/fcvm.2021.722340

Article  PubMed  PubMed Central  Google Scholar 

Helms AS, Alvarado FJ, Yob J, Tang VT, Pagani F, Russell MW et al (2016) Genotype-dependent and -independent calcium signaling dysregulation in human hypertrophic cardiomyopathy. Circulation 134(22):1738–1748

Article  CAS  PubMed  PubMed Central  Google Scholar 

Okuda S, Sufu-Shimizu Y, Kato T, Fukuda M, Nishimura S, Oda T et al (2018) CaMKII-mediated phosphorylation of RyR2 plays a crucial role in aberrant Ca release as an arrhythmogenic substrate in cardiac troponin T-related familial hypertrophic cardiomyopathy. Biochem Biophys Res Commun 496(4):1250–1256. https://doi.org/10.1016/j.bbrc.2018.01.181

Article  CAS  PubMed  Google Scholar 

Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO (2009) Sudden deaths in young competitive athletes. Circulation 119(8):1085–1092. https://doi.org/10.1161/circulationaha.108.804617

Article  PubMed  Google Scholar 

Finocchiaro G, Bhatia RT, Westaby J, Behr ER, Papadakis M, Sharma S et al (2023) Sudden cardiac death during exercise in young individuals with hypertrophic cardiomyopathy. JACC: Clin Electrophysiol 9(6):865–7. https://doi.org/10.1016/j.jacep.2022.12.007

Sharma S, Pelliccia A, Gati S (2020) The ‘Ten Commandments’ for the 2020 ESC guidelines on sports cardiology and exercise in patients with cardiovascular disease. Eur Heart J. https://doi.org/10.1093/eurheartj/ehaa735

Article  PubMed  PubMed Central  Google Scholar 

Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P et al (2020) 2020 AHA/ACC Guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 142(25):e533–e557. https://doi.org/10.1161/CIR.0000000000000938

Article  PubMed  Google Scholar 

Sweeting J, Ingles J, Ball K, Semsarian C (2018) A control theory-based pilot intervention to increase physical activity in patients with hypertrophic cardiomyopathy. Am J Cardiol 122(5):866–871. https://doi.org/10.1016/j.amjcard.2018.05.023

Article  PubMed  Google Scholar 

Pelliccia A, Lemme E, Maestrini V, Di Paolo FM, Pisicchio C, Di Gioia G et al (2018) Does sport participation worsen the clinical course of hypertrophic cardiomyopathy? Circulation 137(5):531–533. https://doi.org/10.1161/circulationaha.117.031725

Article  PubMed  Google Scholar 

Lampert R, Ackerman MJ, Marino BS, Burg M, Ainsworth B, Salberg L et al (2023) Vigorous exercise in patients with hypertrophic cardiomyopathy. JAMA Cardiol 8(6). https://doi.org/10.1001/jamacardio.2023.1042

Gati S, Sharma S (2022) Exercise prescription in individuals with hypertrophic cardiomyopathy: what clinicians need to know. Heart 108(24):1930–1937. https://doi.org/10.1136/heartjnl-2021-319861

Article  PubMed